Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation

Transplantation

Volumn 64, Issue 11, 1997, Pages 1624-1627

  Rostaing, Lionel ^a   Henry, Sabine ^b   Cisterne, Jean Marc ^b   Duffaut, Michel ^b   Icart, Josette ^b   Durand, Dominique ^b  

^a Service de Néphrologie Transplant d'Organes Chu Rangueil   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CREATININE; CYCLOSPORIN A; LAMIVUDINE; STEROID; VIRUS DNA;

ADULT; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; RECURRENT INFECTION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CYCLOSPORINE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LAMIVUDINE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PILOT PROJECTS; VIRUS REPLICATION;

EID: 0031456837     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199712150-00025     Document Type: Article

References (23)

1. Friedlaender MM, Kaspa RT, Rubinger D, Silver J, Popovtzer MM. Renal transplantation is not contraindicated in asymptomatic carriers of hepatitis B surface antigen. Am J Kidney Dis 1989; 14: 204.
2. Huang CC, Lai MK, Fong MT. Hepatitis B liver disease in cyclosporine-treated renal allograft recipients. Transplantation 1990; 49: 540.
3. Grekas D, Diondis C, Mandraveli K, et al. Renal transplantation in asymptomatic carriers of hepatitis B surface antigen. Nephron 1995; 69: 267.
4. Bang BK, Yang CW, Yoon SA, et al. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in cyclosporin-treated renal allograft recipients. Nephron 1995; 70: 397.
5. Fornairon S, Pol S, Legendre C, et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996; 3 62: 297.
6. Agarwal SK, Dash SC, Tiwari SC, Mehta SN, Saxena S, Malhotra KK. Clinicopathologic course of hepatitis B infection in surface antigen carriers following living-related renal transplantation. Am J Kidney Dis 1994; 24: 78.
7. Parfrey PS, Forbes RDC, Hutchinson TA, et al. The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 1985; 39: 610.
8. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991; 114: 629.
9. Grotz W, Gondolf K, Rasenack J, Berthold H, Rump LC, Schollmeyer P. Imminent liver failure in a hepatitis B-positive renal-allograft recipient: successful therapy with interferon-α. Nephrol Dial Transplant 1995; 10: 1932.
10. Rostaing L, Modesto A, Baron E, Cisterne JM, Chabannier MH, Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitic C. Nephron 1996; 74: 512.
11. Pol S, Saltiel C, Legendre C, et al. Effectiveness of adenine arabinoside 5′- monophosphate in kidney transplant recipients with chronic active hepatitis B. Nephrol Dial Transplant 1994; 9: 820.
12. Dienstag JL, Perillo RP, Schiff ER, Bartholomeu M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 33: 1657.
13. Benhamou Y, Dohin E, Lunel-Fabiani F. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet 1995; 345: 396.
14. Ben-Ari Z, Shmueli D, Mor E, Shapira Z, Tur-Kaspa R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 1997; 63: 393.
15. Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis B seronegative subjects. Lancet 1988; 2: 1273.
16. Degos F, Lugassy C, Degott C, et al. Hepatitis B virus and hepatitis-B-related viral infection in renal transplant recipients. Gastroenterology 1988; 97: 151.
17. Flagg GL, Silberman H, Takamoto SK, Berne TV. The influence of hepatitis B infection on the outcome of renal allotransplantation. Transplant Proc 1987; 19: 2155.
18. Hadziyannis SJ. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hep Rev 1995; 1: 7.
19. Terrault NA, Holland CC, Ferrel L, et al. Interferon alpha for recurrent hepatitis B infection after liver transplantation. Liver Transplant Surg 1996; 2: 132.
20. Ouzan D, Vicant E, Chossegros P, Rey JF, Trépo C. Meta-analysis of randomized controlled study of vidarabine or its monophosphate derivative in the treatment of HBe Ag DNA positive chronic hepatitis [Abstract]. J Hepatol 1988; 5: 128.
21. Bartholomeu MM, Jansen RW, Jeffers LJ, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349: 20.
22. Schuurman R, Nijhuis M, van Leeuwen R, Schipper P, de Jong D, Collis P. Rapid changes in human immunodeficiency virus type I RNA load and appearance of drug-resistant virus population in persons treated with lamivudine (3 TC). J Infect Dis 1995; 171: 1411.
23. Koziel MJ. Immunology of viral hepatitis. Am J Med 1996; 100: 98.